Lipoprotein Signal Peptidase Inhibitors with Antibiotic Properties Identified through Design of a Robust In Vitro HT Platform
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Cell Chemical Biology
- Vol. 25 (3) , 301-308.e12
Abstract
No abstract availableKeywords
Funding Information
- The Scripps Research Institute
- Opko Health, Inc.
This publication has 44 references indexed in Scilit:
- Myxobacterium-Produced Antibiotic TA (Myxovirescin) Inhibits Type II Signal PeptidaseAntimicrobial Agents and Chemotherapy, 2012
- Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United StatesChemical Research in Toxicology, 2011
- Lipoproteins of Bacterial PathogensInfection and Immunity, 2011
- Broad-Spectrum Antibiotic Activity of the Arylomycin Natural Products Is Masked by Natural Target MutationsChemistry & Biology, 2010
- SOS regulatory elements are essential for UPEC pathogenesisMicrobes and Infection, 2010
- Maturation of Streptococcus pneumoniae lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulenceMolecular Microbiology, 2007
- Synthesis of a C-Terminal Thioester Derivative of the Lipopeptide Pam2CSKKKKG Using Fmoc SPPSSynlett, 2007
- A Database of Bacterial Lipoproteins (DOLOP) with Functional Assignments to Predicted LipoproteinsJournal of Bacteriology, 2006
- Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilutionClinical Microbiology and Infection, 2003
- Linear Non-competitive Inhibition of Solubilized Human γ-Secretase by Pepstatin A Methylester, L685458, Sulfonamides, and BenzodiazepinesJournal of Biological Chemistry, 2002